Avegen Company Profile

Background

Founded in 2015, Avegen is a health-tech company headquartered in London, UK, with additional operations in Pune, India. The company specializes in developing digital health solutions aimed at enhancing patient care and improving clinical workflows. Avegen's mission is to empower patients and healthcare providers through innovative digital tools, thereby making healthcare more accessible and efficient.

Key Strategic Focus

Avegen's strategic focus centers on two primary objectives:

1. Patient Self-Management Solutions: Developing digital products that enable patients to manage their health conditions effectively. These solutions incorporate behavioral change techniques and personalized guidance to foster healthier lifestyles.

2. Operational Efficiency for Healthcare Providers: Creating customizable digital tools that streamline clinical workflows, reduce costs, and enhance operational efficiency within healthcare settings.

The company's proprietary platform, HealthMachine®, serves as the foundation for these solutions, offering a scalable and modular approach to digital health product development.

Financials and Funding

Avegen has primarily been self-funded since its inception, allowing the company to maintain control over its strategic direction and operations. As of recent estimates, Avegen's annual revenue is approximately $27.8 million, with a revenue per employee of $270,000.

Pipeline Development

Avegen has successfully launched 18 digital health products across various chronic disease areas, including:

Diabetic Peripheral Neuropathy: A digital solution supporting individuals with diabetes experiencing peripheral neuropathy, launched in Thailand in January 2025.

Multiple Sclerosis: In collaboration with King's College London, Avegen developed a solution to assist individuals with multiple sclerosis in managing fatigue, enhancing communication between patients and healthcare providers.

Digestive Health: A mobile application empowering individuals suffering from diarrhea to proactively manage and understand their condition, launched in January 2024.

Cardiac Rehabilitation: A digital health product designed to reduce relapse in heart conditions and improve patient adherence to cardiac rehabilitation programs, implemented in collaboration with the Bucks, Oxford, and West Berkshire Integrated Care Board.

Prostate Cancer: The Pro-Recover app supports patients before and after robotic prostatectomy, developed in partnership with Professor Prasanna Sooriakumaran and launched in summer 2023.

Pulmonary Hypertension: A solution supporting individuals with pulmonary arterial hypertension, live in eight European countries, assisting over 5% of the diagnosed patient population in those markets.

Long-Term Conditions: The Orbi app aims to improve the mental health of individuals with long-term physical health conditions, based on research from King's College London's Health Psychology Section.

Pregnancy: Together for Her (TFH) is a digital care program empowering expectant mothers with accurate information and personalized guidance, launched in July 2020 and installed over 2 million times.

Paranoia: The STOP app delivers therapy to patients experiencing paranoia, developed with King's College London and currently undergoing clinical trials.

HIV: Klick is a nurse-led digital solution for patients living with HIV, integrated with Chelsea and Westminster Hospital Foundation Trust's outpatient services, supporting over 6,000 patients.

Technological Platform and Innovation

Avegen's HealthMachine® platform is a cloud-hosted, modular system that enables the rapid development and deployment of digital health products. Key features include:

Interactive Learning and Capability Building: Personalized, interactive information to enhance patient engagement and education.

Medical Grade Products and Quality Excellence: Compliance with ISO13485 and ISO27001 standards, ensuring high-quality and secure digital health solutions.

Behavioral Change Support: Incorporation of goal setting, tracking, notifications, and nudges to promote healthy behaviors.

Self-Management Support: Utilization of behavior design principles and AI technology to deliver personalized experiences for individuals with chronic conditions.

Secure Communication: Multiple communication channels, including SMS, emails, and in-app messaging, to facilitate patient-provider interactions.

Digital Triaging and Appointment Management: Remote capture of patient information and streamlined scheduling to improve access to care.

Configurable Clinical Workflows: Customizable workflows to reduce administrative burdens and enhance clinical efficiency.

Leadership Team

Dr. Nayan Kalnad, Co-founder and CEO: A clinician with over 14 years of experience in digital healthcare and pharmaceutical R&D, previously with Janssen Healthcare Innovation.

Neeraj Apte, Co-founder and CTO: An entrepreneur and engineer with a background in software development, dedicated to creating digital solutions that enhance patient experiences.

Jeremy Hill, Chief Commercial Officer: A senior commercial leader with experience in pharmaceuticals, medical devices, and digital health tech sectors, focusing on launching SaaS and AI-enabled innovations.

Prasad Potnis, Chief Operating Officer: An experienced leader committed to driving excellence by prioritizing customer satisfaction, growth, and operational efficiency.

Saurabh Jambure, Director of Operations: A professional with a passion for building products and teams that make a difference, dedicated to the digital health industry.

Jamie Campbell, Business Development Director: With a background in pharmaceutical management consultancy, Jamie focuses on improving healthcare through digital health platforms.

Sanjay Tiwary, Senior Director of Engineering: With over two decades of experience in building enterprise software products, Sanjay leads high-performing engineering teams at Avegen.

Leadership Changes

There have been no recent significant changes or appointments within Avegen's leadership team.

Competitor Profile

Market Insights and Dynamics

The digital health market is experiencing rapid growth, driven by the increasing prevalence of chronic diseases, advancements in technology, and the need for cost-effective healthcare solutions. The global digital health market is projected to reach significant valuations in the coming years, with substantial growth potential.

Competitor Analysis

Key competitors in the digital health space include:

Ada Health: Specializes in AI-driven health assessments and symptom checking.

Alcidion Group: Focuses on healthcare analytics and informatics solutions.

Ampliz: Provides healthcare data intelligence and analytics services.

Definitive Healthcare: Offers commercial intelligence solutions for the healthcare industry.

IQVIA: Provides advanced analytics, technology solutions, and contract research services.

Sisense: Specializes in business intelligence and data analytics platforms.

Sg2: Offers healthcare analytics and consulting services.

These companies focus on various aspects of digital health, including AI-driven diagnostics, healthcare analytics, and patient engagement platforms.

Strategic Collaborations and Partnerships

Avegen has established significant collaborations to enhance its market position and innovation capacity:

King's College London: Partnered to develop solutions for multiple sclerosis and paranoia, leveraging academic research to create effective digital health products.

Chelsea and Westminster Hospital Foundation Trust: Collaborated to implement the Klick digital solution for HIV patients, integrating with outpatient services to improve patient management.

Bucks, Oxford, and West Berkshire Integrated Care Board (BOB-ICB): Worked together to create a cardiac rehabilitation digital health product aimed at reducing relapse in heart conditions.

Professor Prasanna Sooriakumaran: Partnered to develop the Pro-Recover app for prostate cancer patients, enhancing pre- and post-operative care.

Operational Insights

Avegen's strategic considerations include:

Platform Approach: Utilizing the HealthMachine® platform to configure existing modules, reducing development time and allowing for the launch of digital health products in 3-4 months instead of 1-2 years.

Global Reach: Operating in multiple countries, including the UK, US, Germany, Spain, Japan, India, UAE, Belgium, Netherlands, Lebanon, Canada, Thailand, Ireland, Sweden, and Norway, demonstrating a broad market presence.

Client Base: Serving over 30 clients, including major pharmaceutical companies, healthcare providers, and research institutes, indicating a strong and diverse client portfolio.

Strategic Opportunities and Future Directions

Avegen aims to:

Democratize Access to Digital Health Products: By making it easy and cost-effective for health organizations to build, deploy, and scale effective digital tools quickly.

Expand Global Health Markets: Onboarding new healthcare organizations and pharmaceutical companies to reach millions more patients with a wider range of long-term health conditions.

Enhance Patient Engagement: Making digital healthcare support as easy to access as social media, aiming to integrate digital health products into routine patient care.